Bristol-Myers Squibb Company's Tequin Tied To Blood-Sugar Problems

Serious blood-sugar complications among people taking the antibiotic Tequin are more common than had been believed, a new study in older people suggests. The research, released Wednesday by the New England Journal of Medicine, is further evidence the drug may pose special risks for diabetics. The study found hazards for others as well.

Back to news